Patent details

301074 Product Name: onasemnogene abeparvovec, in enige vorm zoals beschermd door het basisoctrooi

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301074
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2185712
Status:
Withdrawn
Application number:
301074
Procedural language:
Dutch
First Applicant Residence Country:
France (FR)

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1443
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/05/2020
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
18/11/2020
First Marketing Authorization date:
18/05/2020
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
18/11/2020
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
12/01/2023
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
18/11/2020
 
 

 

Name:
GENETHON
Address:
1 bis rue de l'Internationale Boîte Postale 60, 91002 Evry Cedex, France (FR)

From:
18/11/2020
 
 

 

Name:
Centre National de la Recherche Scientifique
Address:
3, rue Michel-Ange, 75016 PARIS, France (FR)

Agent

Name:
ir. H.A. Witmans c.s.
From:
18/11/2020
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
03/23
Publication date:
18/01/2023
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
48/20
Publication date:
25/11/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
16/01/2023 Outgoing Correspondence Letter confirmation withdrawal 1 PDF /9/6/0/5/2/0800625069/docs/301074_11_526119l193.pdf
12/01/2023 SPC Documents Withdrawal SPC 1 PDF /9/6/0/5/2/0800625069/docs/301074_12_supplprotectioncertificate20230112042341896.pdf
18/11/2020 SPC Documents Annex SPC 3 PDF /9/6/0/5/2/0800625069/docs/301074_0_supplprotectioncertificate20201118123055307.pdf
18/11/2020 SPC Documents Annex SPC 7 PDF /9/6/0/5/2/0800625069/docs/301074_1_supplprotectioncertificate20201118123055511.pdf
18/11/2020 SPC Documents Marketing Authorization SPC 3 PDF /9/6/0/5/2/0800625069/docs/301074_2_supplprotectioncertificate20201118123055200.pdf
18/11/2020 SPC Documents Annex SPC 2 PDF /9/6/0/5/2/0800625069/docs/301074_3_supplprotectioncertificate20201118123055457.pdf
18/11/2020 SPC Documents Annex SPC 18 PDF /9/6/0/5/2/0800625069/docs/301074_4_supplprotectioncertificate20201118123055374.pdf
18/11/2020 Front Page Front Page 1 PDF /9/6/0/5/2/0800625069/docs/301074_5_i1frontpage20201118142218638.pdf
18/11/2020 Outgoing Correspondence Confirmation receipt request 1 PDF /9/6/0/5/2/0800625069/docs/301074_6_379100l174.pdf
18/11/2020 Application Form First filed application form 3 PDF /9/6/0/5/2/0800625069/docs/301074_7_applicationform20201118123055042.pdf
18/11/2020 SPC Documents Summary of the characteristics of the product 19 PDF /9/6/0/5/2/0800625069/docs/301074_8_supplprotectioncertificate20201118123055251.pdf
18/11/2020 SPC Documents Accompanying letter SPC 2 PDF /9/6/0/5/2/0800625069/docs/301074_9_supplprotectioncertificate20201118123055149.pdf
18/11/2020 Publication Publication 1 PDF /9/6/0/5/2/0800625069/docs/301074_10_i1document20201118142219203.pdf